RxDoctor Payments Data

Michael Sevilla, MD

Family Medicine · Salem, OHNPI 1114032901

Payments from drug & device makers

$6,234in general payments, 2019–2025

Across 319 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seqirus USA Inc$880
  • AbbVie$630
  • Pfizer$542
  • AstraZeneca$444
  • Johnson & Johnson$339
  • Astellas Pharma US Inc$339
  • plus $3K from 31 others

What the payments were for

  • Consulting fees$83413%
  • Food & beverage$5,17383%
  • Education$2274%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,234 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$141,550
Medicare patients
222
Services billed
2,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$107,060
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$35,526
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog31$33,065
OzempicSemaglutide28$33,018
JardianceEmpagliflozin36$31,512
EntrestoSacubitril/Valsartan19$17,402
MyrbetriqMirabegron28$15,637
XareltoRivaroxaban13$13,332
LivaloPitavastatin Calcium20$12,496
Breo ElliptaFluticasone/Vilanterol17$8,897
Lantus SolostarInsulin Glargine,hum.Rec.Anlog66$8,127
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$6,420
Humalog Kwikpen U-100Insulin Lispro26$6,339
RestasisCyclosporine11$5,098
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$5,040

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$542$107,060131 claims
GSKTrelegy Ellipta, Breo Ellipta$290$44,42455 claims
Novo NordiskOzempic$283$33,01828 claims
Boehringer IngelheimJardiance$175$31,51236 claims
NovartisEntresto$25$17,40219 claims
Astellas Pharma US IncMyrbetriq$339$15,63728 claims
Johnson & JohnsonXarelto$339$13,33213 claims
Kowa Pharmaceuticals America, Inc.Livalo$72$12,49620 claims
AbbVieRestasis, Synthroid$630$6,60449 claims
Lilly USA, LLCHumulin N$194$2,18818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Salem

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →